Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3

T Maruyama, J Li, JP Vaque, JE Konkel, W Wang… - Nature …, 2011 - nature.com
T Maruyama, J Li, JP Vaque, JE Konkel, W Wang, B Zhang, P Zhang, BF Zamarron, D Yu…
Nature immunology, 2011nature.com
The molecular mechanisms that direct transcription of the gene encoding the transcription
factor Foxp3 in CD4+ T cells remain ill-defined. We show here that deletion of the DNA-
binding inhibitor Id3 resulted in the defective generation of Foxp3+ regulatory T cells (Treg
cells). We identify two transforming growth factor-β1 (TGF-β1)-dependent mechanisms that
were vital for activation of Foxp3 transcription and were defective in Id3−/− CD4+ T cells.
Enhanced binding of the transcription factor E2A to the Foxp3 promoter promoted Foxp3 …
Abstract
The molecular mechanisms that direct transcription of the gene encoding the transcription factor Foxp3 in CD4+ T cells remain ill-defined. We show here that deletion of the DNA-binding inhibitor Id3 resulted in the defective generation of Foxp3+ regulatory T cells (Treg cells). We identify two transforming growth factor-β1 (TGF-β1)-dependent mechanisms that were vital for activation of Foxp3 transcription and were defective in Id3−/− CD4+ T cells. Enhanced binding of the transcription factor E2A to the Foxp3 promoter promoted Foxp3 transcription. Id3 was required for relief of inhibition by the transcription factor GATA-3 at the Foxp3 promoter. Furthermore, Id3−/− T cells showed greater differentiation into the TH17 subset of helper T cells in vitro and in a mouse asthma model. Therefore, a network of factors acts in a TGF-β-dependent manner to control Foxp3 expression and inhibit the development of TH17 cells.
nature.com